24.01.2019 • News • Cerbios • People • HPAPIs

Francesca Scarpitta Joins Cerbios as Director of HPAI Manufacturing Units

Cerbios has appointed Francesca Scarpitta as director of the company’s high potency active ingredients (HPAIs) production units.

Francesca Scarpitta has joined Cerbios as director of the companys HPAI... — Francesca Scarpitta has joined Cerbios as director of the company's HPAI manufacturing units. Source: Cerbios

"Dr. Scarpitta brings in a strong expertise and knowledge in the transfer of API manufacturing from R&D. Scale-up improvements following the development of the HPAI from clinical to commercial scale is one of her key competences,“ said Gabriel Haering, CEO of Cerbios.

Scarpitta holds a PhD in organic chemistry at the University of Pavia, Italy. Since 2000 she held various positions in the API industry in Italy and in Israel.

Company

Cerbios-Pharma SA

Via Figino 6
6917 Barbengo – Lugano
Switzerland

Company contact

I am interested in:

an offer
a callback
detailed information

Your request

salutation first name last name

country phone email

Please note our data protection information for the contact form.

Interview

Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Special Issue

Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.